Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.363   +0.051 (16.35%)  0.31 - 0.476  6,674,900

Overview

 
Avg Volume (4 weeks):787,515
4 Weeks Range:0.261 - 0.49
4 Weeks Price Volatility (%):
44.54%
52 Weeks Range:0.252 - 0.75
52 Weeks Price Volatility (%):
22.29%
Average Price Target: 3.00
Price Target Upside/Downside: +2.637

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22